Three-dimensional organ segmentation-derived CT attenuation parameters for assessing hepatic steatosis in chronic hepatitis B patients.

The utility of CT-derived parameters for hepatic steatosis assessment has primarily focused on non-alcoholic fatty liver disease. This study aimed to evaluate their applicability in chronic hepatitis B (CHB) through a retrospective analysis of 243 CHB patients. Using deep-learning-based 3D organ segmentation on abdominal CT scans at 100 kVp, the mean volumetric CT attenuation of the liver and spleen was automatically measured on pre-contrast (liver (L)_pre and spleen (S)_pre) and post-contrast (L_post and S_post) portal venous phase images. To identify mild, moderate, and severe steatosis (S1, S2, and S3 based on the controlled attenuation parameter), L_pre showed areas under the receiver operating characteristic curve (AUROCs) of 0.695, 0.779, and 0.795, significantly higher than L-S_pre (0.633, 0.691, and 0.732; Ps = 0.02, 0.003, and 0.03). Post-contrast parameters demonstrated slightly lower AUROCs than their pre-contrast counterparts (Ps = 0.15-0.81). Concomitant hepatic fibrosis influenced diagnostic performance, with CT parameters performing better in patients without severe fibrosis than those with (F3-4 on transient elastography), though statistical significance was only observed for L-S_post in severe steatosis (P = 0.037). In conclusion, CT attenuation-based parameters extracted through automated 3D analysis show promise as a tool for assessing hepatic steatosis in patients with CHB.